Shanghai Institute Of Biological Products

This study is testing a new version of the seasonal flu vaccine to see how well it triggers an immune response and how safe it is for people aged 60 and above. It will involve 1,200 participants who will receive either the new vaccine or a currently available one for comparison. …

This study is testing the safety and immune response of a new mpox vaccine called MVA-SIBP. It will enroll 180 healthy children and adults in the Democratic Republic of the Congo who have never had mpox or a related vaccine. The goal is to gather data to support approval of an af…

This early-stage trial is testing a new injection called SIBP-A16 to see if it can help prevent serious illness from Respiratory Syncytial Virus (RSV) in babies. The study will enroll 36 premature and full-term infants to check the safety of different doses and see how the body p…